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Abstract The kinetics of 18 amino acids, ammonia
(NH3) and urea (UREA) in 18 liver cell bioreactor runs
were analyzed and simulated by a two-compartment
model consisting of a system of 42 diﬀerential equations.
The model parameters, most of them representing
enzymatic activities, were identiﬁed and their values
discussed with respect to the diﬀerent liver cell bioreactor
performance levels. The nitrogen balance based model
was used as a tool to quantify the variability of runs and
to describe diﬀerent kinetic patterns of the amino acid
metabolism, in particular with respect to glutamate
(GLU) and aspartate (ASP).
Keywords Systems biology Æ Metabolic network Æ Liver
support Æ Bioreactor
Introduction
Bioreactor technology for extracorporeal liver support
using primary human liver cells has been developed
within the last decade [1]. The design of a bioreactor for
maintaining the hepatocyte’s full functionality is of great
importance. The used multi-compartment bioreactor
consists of three interwoven, independent capillary
membrane systems. Two of them (compartments 1 and
2, in the following aggregated to the ‘perfusion com-
partment’) provide decentralized plasma ﬂow and the
third one (compartment 3) provides oxygen supply to
the cells, which are localized in the extracapillary space
(compartment 4, ‘liver cell compartment’). This three-
dimensional spatial structure represents an artiﬁcial
equivalent of the hepatic vasculature at the lobular level.
The bioreactor is integrated into a perfusion system that
enables monitoring and control of system conditions
(see Fig. 1). Previous studies have shown that primary
liver cells reconstitute to tissue-like structures after
inoculation into the bioreactor and that they maintain
metabolic activities over several weeks [2–4]. This bio-
reactor therefore provides a valuable tool to analyze the
dynamics and network structures of the physiological
and molecular interactions of liver cells under stan-
dardized conditions that closely reﬂect the situation in
the natural organ.
Recently, data from this bioreactor system has been
analyzed statistically as well as by fuzzy cluster and rule
based data mining and pattern recognition methods in
order to identify early performance predictors for the
bioreactor’s long-term performance [5–7]. With respect
to the prominent role of hepatocytes in the amino acid
metabolism, the analysis and modeling of metabolic
pathways of amino acids could provide important
information on the functional state of hepatocytes
cultured in vitro. In initial studies the role of amino acid
regulation in extracorporeal liver support systems was
analyzed [8]. More recently, three diﬀerent modeling
paradigms, i.e. correlation networks, Bayesian networks
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characterize the concentration proﬁles of six amino acids
and related nitrogen-containing compounds in bioreactor
cultures of primary human liver cells [6]. The present
work reports on the model based analysis of the mea-
sured kinetics of 18 amino acids as well as ammonia
(NH3) and urea (UREA) of 18 liver cell bioreactor runs.
Materials and methods
Cells and bioreactors
Primary human liver cells were isolated according to a
method described elsewhere [9] from human donor livers
(n=18) that were not suitable for transplantation due to
organ injury. After isolation, cells were cultured within
bioreactors over 7–34 days. (This broad variability in
duration is caused by their use for liver support from the
seventh day onwards and by the performance. Low
performance runs were ﬁnished earlier. High perfor-
mance runs were continued for a longer period of time.
However, only the ﬁrst 6 days of the runs were analyzed
in this study.) Concentrations of free amino acids in the
culture perfusates were determined by an automated
reversed phase high performance liquid chromatography
system (RP-HPLC) with precolumn derivatization using
the ophthaldialdehyde method [10]. NH3 and UREA
concentrations were determined using routine clinical
analyzers (Roche Diagnostics, Heidelberg, Germany).
With respect to the model based analysis, two com-
partments of the multi-compartment capillary mem-
brane bioreactor system were considered: The ‘liver cell
compartment’ with the volume V2=600 mL contains
the liver cells in the inter-capillary space. The ‘perfusion
compartment’ with the volume V1=900 mL supplies a
stream through the inside of the capillaries. This perfu-
sion stream carries the concentrations of the compounds
that are supplied to or removed from the bioreactor.
Decentralized mass exchange at low gradients is
achieved by independent perfusion of two medium
capillary systems, enabling diﬀerent perfusion modes
[10]. In this study, counter-directional medium ﬂow was
performed to facilitate rapid matter distribution. Due to
the high ﬂow rate of the perfusion stream
(250 mL min
 1), an almost ideal mixing within the
perfusion compartment can be assumed (Fig. 1). To this
perfusion compartment two time-variant inﬂow streams
are added with the ﬂow rates FA(t) and FB(t) as deﬁned
by Eq. (1). FA(t) follows a step function from
FA1=150 mL h
 1 down to FA2=50 mL h
 1 switching
at tA(=1 day). FB(t) switches from FB1=0 up to
FB2=1 mL h
 1 at the time tB (see Table 4). The outﬂow
rate F0(t) to the waste equals the sum of both inﬂow
rates. (This is realized by overﬂow keeping a constant
pressure in the perfusion compartment).
FAðtÞ¼ FA1 for t\tA
FA2 for t   tA
;
 
FBðtÞ¼ FB1 for t\tB
FB2 for t   tB
;
 
F0ðtÞ¼ FAðtÞþFBðtÞ:
ð1Þ
The inﬂow rate FA(t) carries the 18 amino acids and
NH3 at the concentrations cAi (see Table 1). The inﬂow
rate FB(t) carries only the amino acid aspartate (ASP) at
the concentration cB15=1,500 lmol L
 1, i.e. cBi=0 for
all i „ 15. The time courses of the concentrations c0i(t)i n
the outﬂow stream may be considered to describe the
response of the medium to the inoculation of the
bioreactor with cells. These concentrations are in steady-
state at c0i(0)=cAi prior to inoculation. Due to the
almost ideal mixing in the perfusion compartment, the
concentrations c0i(t) in the perfusion stream are the same
as in the outﬂow stream.
Data
A data set with the elements ci,j,k (i=1,...,20; j=1,...,18;
k=1,...,K) for 20 kinetic variables and 18 bioreactor
runs at K time points tk was analyzed. The kinetics over
the ﬁrst 6 days of the bioreactor runs were analyzed here
(tk=6 days). Concentrations of NH3 and UREA were
measured daily (tk=0–6 days). Amino acid concentra-
tions were determined up to the third day daily and
every third day afterwards (tk=0, 1, 2, 3, 6 days). The
samples for the measurement of the ci,j,k were taken from
the waste of the liver cell bioreactor system (see Fig. 1)
which was emptied daily after accumulation of the
outﬂow stream over the period of 24 h.
The model based analysis described focuses on the
amino acid metabolism as quantiﬁed by the measured
time series of the concentrations of 18 amino acids
(i=1,..., 18; see Table 1) as well as of NH3 (i=19) and
UREA (i=20).
Each run was labeled by Lj 2 {‘low’, ‘medium’,
‘high’} describing the performance with respect to the
long-term maintenance of the functionality of the liver
cells within the bioreactor. Seven runs were labeled
‘high’ (j=1,..., 7), seven runs ‘medium’ (j=8,..., 14) and
four runs ‘low’ (j=15,..., 18). This performance labeling
Fig. 1 Scheme of the liver cell bioreactor with the perfusion circuit,
the two inﬂow streams and the outﬂow stream. Measured data were
acquired from the waste
332was provided by an expert based on his assessment of
altogether 99 variables that were measured to quantita-
tively characterize the system.
Diﬀerential equation system
The diﬀerential equation system (2.1–2.10) was devel-
oped to describe the measured kinetics of the 18 amino
acids as well as of NH3 and UREA (Table 1). This
model takes into account two compartments as
described in Cells and bioreactors, the ‘perfusion com-
partment’ and the ‘liver cell compartment’.
The Eq. (2.1) describe the dynamics of the compo-
nents i in the perfusion compartment by four terms: The
ﬁrst and second term represent the fresh medium inﬂow
with the volumetric rates FA(t)a n dFB(t), respectively,
from the reservoir into the perfusion compartment with
the volume V1. The reservoir concentrations cAi of the
components i are speciﬁed in Table 1. The volumetric
rates FA(t) and FB(t) are speciﬁed by Eq. (1). The third
term in Eq. (2.1) denotes the outﬂow from the perfusion
compartment into the waste with the volumetric rate
F0(t). The last term describes the diﬀusion between the
perfusion and the liver cell compartment with its rate
being proportional to the diﬀerence of the concentration
c0,i in the perfusion compartment and the concentration
ci in the liver cell compartment. The parameter p0 is
proportional to the diﬀusion coeﬃcient and assumed to
be the same for all compounds to simplify parameter
identiﬁcation.
The Eqs. (2.2–2.9) formulate the changes of the
concentrations ci in the liver cell compartment with the
volume V2 due to the exchange with the perfusion
compartment (the ﬁrst term on the right side of each
diﬀerential equation) and the metabolic reactions (the
following term(s) on the right side of each diﬀerential
equation) as drawn schematically in Fig. 2.
dc0;i
dt
¼FAðtÞ=V1 cAiþFBðtÞ=V1 cBi F0ðtÞ=V1 c0;i
 p0=V1 ðc0;i ciÞ fori¼1;:::;21
ð2:1Þ
dci
dt
¼ p0=V2  ð c0;i   ciÞ pi   ci; for i ¼ 1;:::;14 ð2:2Þ
dc15
dt
¼ p0=V2  ð c0;15   c15Þþp16   c16 þ p18   c17
 ð p15   c19 þ p17 þ p19   c19=ðp20 þ c15ÞÞ   c15;
ð2:3Þ
dc16
dt
¼ p0=V2  ð c0;16   c16Þþp15   c15   c19   p16   c16;
ð2:4Þ
dc17
dt
¼p0=V2 ðc0;17 c17Þþ
X 10
i¼1
pi si ciþp17 c15
þp22 c18  ðp18þp21 c19þp23Þ c17;
ð2:5Þ
dc18
dt
¼p0=V2 ðc0;18 c18Þþp21 c17 c19 p22 c18; ð2:6Þ
dc19
dt
¼ p0=V2  ð c0;19   c19Þþ
X 14
i¼11
pi   si   ci
þ p23  ð 1   gðtÞÞ   c17 þ p16   c16 þ p22   c18
 ð p19   c15=ðp20 þ c15Þþp15   c15 þ p21   c17Þ c19;
ð2:7Þ
dc20
dt
¼ p0=V2  ð c0;20   c20Þþp19   c15=ðp20 þ c15Þ c19;
ð2:8Þ
dc21
dt
¼ p0=V2  ð c0;21   c21Þþp23   gðtÞ c17 ð2:9Þ
g(t) ¼ 0 for t\3d else gðtÞ¼p24 ð2:10Þ
The model drawn in Fig. 2 and its Eqs. (2.1–2.10) were
constructed based on the mean kinetics of 20 measured
variables averaged over the seven high-performance runs
H1–H7 as shown in Fig. 3. The kinetics of these seven
individual runs are highly correlated with their correla-
tion coeﬃcients being greater than 0.8 for at least six of
the seven high-performance runs and the 11 amino acids
MET, SER, THR, ARG, HIS, GLY, TRP, LEU, VAL,
PHE, and ILE [6]. The dynamics of these amino acids
are characterized by monotonously, almost exponen-
tially decreasing kinetics [6]. Their dynamics were
therefore described by ﬁrst order reactions as formulated
by the second term in Eq. (2.2). The observed decreasing
kinetics of amino acid concentrations is the net result of
anabolic and catabolic reactions, where the catabolism
of amino acids (which was considered here only)
surpasses the amino acid synthesis and release by
Table 1 Model variables ci and c0,i for the liver cell compartment
and the perfusion compartment, respectively, their initial values
ci(0) and c0,i(0) before inoculation of the bioreactor with liver cells,
the concentration cAi in the inﬂow stream fed with the ﬂow rate
FA(t) according to Eq. (1) and the stoichiometric coeﬃcients si for
nitrogen
Name Model
variables
ci and c0,I
ci(0)=
c0,i(0)=cAi
[lmol L
 1]
Stoichiometric
coeﬃcient si
LEU c1, c0,1 2258 1
HIS c2, c0,2 940 3
ARG c3, c0,3 2604 4
VAL c4, c0,4 987 1
TRP c5, c0,5 464 2
PHE c6, c0,6 1300 1
ILE c7, c0,7 500 1
ALA c8, c0,8 1825 1
TYR c9, c0,9 2215 1
LYS c10, c0,10 327 2
MET c11, c0,11 259 1
SER c12, c0,12 861 1
GLY c13, c0,13 1957 1
THR c14, c0,14 859 1
ASP c15, c0,15 284 1
ASN c16, c0,16 168 2
GLU c17, c0,17 265 1
GLN c18, c0,18 687 2
NH3 c19, c0,19 41 1
UREA c20, c0,20 02
PROT c21, c0,21 0–
333proteolytic activities (which were neglected here). The
second term with the parameters p1,..., p14 in Eq. (2.2)
can be interpreted mainly as amino acid uptake by
transamination and oxidative deamination (see Table 2).
In addition to the 11 amino acids with highly correlated
and monotonously decreasing kinetics, the time courses
of the concentrations of the amino acids ALA, LYS, and
TYR were, for simpliﬁcation, also modeled using Eq.
(2.2). The kinetics of the amino acids ASP, ASN, GLU,
and GLN were modeled in greater detail by Eqs. (2.3–
2.6). Glutamate (GLU) is known to be the central
compound of amino acid metabolism. Its kinetics were
found in [6] to be highly correlated with ASP. ASP was
fed by the inﬂow rate FB(t) (see Cells and bioreactors)t o
avoid or compensate the exhaustion of ASP which is
essential for NH3 elimination via the urea cycle. The
degradation of amino acids is interpreted in a simpliﬁed
form by transamination to GLU for the amino acids
LEU, HIS, ARG, VAL, TRP, PHE, ILE, ALA, TYR,
and LYS (denoted by ‘AAg’ in Fig. 2). The amino acids
MET, SER, GLY, and THR (denoted by ‘AAn’ in
Fig. 2), however, are not transaminated forming GLU,
but deaminated via diﬀerent pathways forming NH3.
The parameters with the indices 15–18, 21–23 as shown
in Fig. 2 and Table 2 describe the metabolic ﬂuxes
between ASP, ASN, GLU, GLN, and NH3. They can be
interpreted in a simpliﬁed way by reactions catalyzed,
e.g., by the enzymes asparaginase, aspartate amino-
transferase (AST), glutamate oxalacetate transaminase
(GOT), glutamine synthetase (GS) and glutamate
dehydrogenase (GLDH). In general, the biochemical
reactions were assumed to be either of linear or bilinear
nature (ﬁrst or second order). In two cases, however,
additional assumptions were required to obtain suﬃ-
cient model ﬁts: (1) For the aggregated modeling of the
NH3 elimination via the urea cycle in the presence of
ASP a non-linear Michaelis-Menten-type kinetics was
used (see Eq. 2.8). This reﬂects the observation that the
UREA formation rate does not signiﬁcantly increase
any more at strongly elevated ASP concentrations (see
ASP and UREA in Fig. 3). (2) Protein synthesis, i.e.
anabolism, seems to be switched on or is strongly
increased after the third day. This was modeled using
Eq. (2.10). The total protein (PROT) was not measured,
but a corresponding variable c21 was hypothetically
introduced by Eq. (2.9) to improve the model ﬁt of the
other 20 variables to the measured data for t>3 days.
The model parameters were identiﬁed by ﬁtting the
model to the measured data ci,j,k minimizing the scaled
mean square error (mse) as deﬁned by Eq. (3) for run j.
The model ﬁtting error mse was scaled by the square of
the maximum of the respective measured variable.
According to Eq. (3), the kinetics c0,i(t) obtained from
the simulation of Eqs. (2.1–2.10) with the initial values
listed in Table 1 were averaged over 24 h (i.e. over the
time interval of the accumulation of the bioreactor
outﬂow in the waste where the samples for the
measurements were taken from daily) and then com-
pared with the measured data ci,j,k.
mse¼
1
I  K
X I
i¼1
1
ðmax
k
ci;j;kÞ
2
X K
k¼1
ci;j;k 
Ztk
tk 24h
c0;iðtÞF0ðtÞdt
, Ztk
tk 24h
F0ðtÞdt
0
B @
1
C A
2
ð3Þ
The diﬀerential equations were solved using a
Runge-Kutta fourth order algorithm. The parameter
identiﬁcation by model ﬁtting minimizing the mse was
performed using a simplex search method. MATLAB
tools (The MathWorks, Inc., Natick, MA, USA) were
used for all calculations.
Results and discussions
The mean time proﬁles of the 20 measured variables
each averaged over the high performance runs H1–H7
are shown in Fig. 3. The results of the model ﬁtting to
these averaged data are shown in Fig. 4 and the identi-
ﬁed model parameters p0,..., p24 are listed in Table 2
(third column). The conﬁdence intervals for the
parameter values (fourth and ﬁfth column in Table 2)
were identiﬁed by repeated model ﬁtting to the randomly
disturbed time series data with means and standard
deviations as shown in Fig. 3. The ﬁt of the modeled
Fig. 2 Structure of the model Eqs. (2.2–2.10). The numbers within
the circles denote the indices i of the corresponding concentrations
ci and the numbers at the arrows denote the indices m of the
corresponding model parameters pm. (The diﬀusion process
modeled by the parameter p0 is not shown here.) ‘AAg’ denotes
the amino acids LEU, HIS, ARG, VAL, TRP, PHE, ILE, ALA,
TYR, and LYS; ‘AAn’ denotes the amino acids MET, SER, GLY,
and THR
334kinetics to the measured data is acceptable for 18 of the
20 variables with the exception of lysine (LYS) and
alanine (ALA). The initial increase of the LYS kinetics
could be hypothetically explained by proteolytic activi-
ties. The ﬁnal increase of ALA can be explained by the
ALA aspartate transferase activity. The decreasing
kinetics of 11 out of the 18 amino acids is explained by
transamination and oxidative deamination forming
GLU and NH3. The feeding of ASP after the third day
results not only in an increase of the concentration of
ASP but also of asparagine (ASN), GLU, and glutamine
(GLN) due to the activities of the enzymes AST, GOT,
GS, and asparaginase (alternatively or additionally the
activity of asparagine synthetase could be included in the
model).
Table 3 lists the model parameter values pm with the
respective model ﬁtting error mse as identiﬁed by indi-
vidual model ﬁtting to the seven high performance runs.
Figs. 5–7 show the results of the model ﬁtting to the data
for the individual high performance runs H1, H5, and
H7, respectively. The kinetics of run H2 (not shown
here) is very similar to the mean kinetics of the seven
high performance runs shown in Fig. 4. The quasi-
stationary concentrations of several amino acids, such as
MET and LEU, are lower in run H5 (see Fig. 6) than in
run H2 (compare Fig. 4). This results in a p0 value,
which is about 6.5· higher for run H5 than for run H2
(see Table 3). While the variability of the parameter
values p1,..., p24 can be explained by diﬀerences in the
liver cell material obtained from diﬀerent individual
donors (having diﬀerent age, weight, liver damage, etc.),
it is not entirely clear at this stage how to explain such
diﬀerent values of the parameter p0 that represents
diﬀusion and potentially other phenomena taking place
across and beyond the membrane between the perfusion
and the liver cell compartment. These issues are
addressed in greater detail in [11] as well as in studies
described in [12] to elucidate the dynamics of electro-
lyte distribution in the bioreactor without liver cells
using tracer experiments and input/output systems
analysis.
The model, which was developed using the kinetic
patterns of high performance runs was also ﬁtted to the
data of the 11 runs with medium and low performance.
The aim of these model studies is to elucidate causes of
low liver cell bioreactor performance. The ﬁt of the
model with 25 parameters to 18 bioreactor runs results
in an array of 25·18 parameters. Three selected
parameters with their values as identiﬁed by ﬁtting the
model to the individual 18 runs are listed in Table 4.
Considering a tolerable model ﬁtting error mse of about
2% or less, the model ﬁt proved satisfactory for six of
the seven high performance runs (with the exception of
run H7) and for two of the seven medium performance
runs (M8 and M10). However, the model ﬁt was
not acceptable for the high performance run H7, the
medium performance runs M9, and M11–M14 as well as
all four low performance runs L15–L18. The main
reason for the insuﬃcient model ﬁts is that the measured
kinetics of leucine (LEU), isoleucine (ILE), valine
(VAL), ALA, and other amino acids are not decreasing
in these runs. This behavior is shown in Fig. 7 for run
H7. In these cases some parameter values, e.g., for p1,
were found to be zero (negative parameter values were
set to zero; see Table 4). These zero parameter values
cause that the medium and low performance runs
displayed in Fig. 8 are artiﬁcially close to each other.
Run H7 labeled as a high performance one appears to be
a medium performance run according to the model
simulation results (see Figs. 7 and 8).
Fig. 3 Mean kinetics (± SD)
of 20 measured variables (18
amino acids, NH3, UREA)
averaged over the kinetics of the
n=7 high performance runs
H1–H7 (n=7)
335Figure 8 displays the identiﬁed model parameters of
the 18 liver cell bioreactor runs after principal com-
ponent analysis (PCA) of the parameter array for the
ﬁrst and second principal components in a biplot [13].
The ﬁrst principal component represents 53% of the
total parameter variance and the ﬁrst and second
principal components together represent almost 64%
of this variance. Most of the parameters p1–p14 (with
the exception of p2, p3, p9) representing transamination
and oxidative deamination activities mainly constitute
the ﬁrst principal component of the parameter array
(see Table 2: PC_1>0.2 for these parameters). These
11 parameters are correlated: The 55 correlation
coeﬃcients calculated between the 11 parameters
Fig. 4 Measured and simulated
kinetics of the concentrations of
18 amino acids, NH3 and
UREA. The measured kinetics
(dots) are those of the mean
proﬁles shown in Fig. 3 (n=7).
The simulated kinetics c0i(t):
(thin lines) are those obtained
from the model (2). The
simulated kinetics c0i(t) were
averaged according to Eq. (3)
over the past 24 h (thick lines)
in order to use them for model
ﬁtting to the measured data that
were acquired from the waste
(outﬂow accumulated over
24 h)
Table 2 Parameters pm of the model (2) with interpretation, esti-
mated values and conﬁdence intervals [pmlow, pmhigh]; enzyme
activities: AST aspartate aminotransferase, GOT glutamate oxal-
acetate transaminase, GS glutamine synthetase, GLDH glutamate
dehydrogenase; values and units of the parameters pm of the model
(2) as identiﬁed by the model ﬁt to the mean kinetics averaged over
the seven high performance runs (Fig. 3); PC_1, PC_2: ﬁrst and
second principal component
m Interpretation/enzymes pm [pmlow, pmhigh] Unit PC_1 PC_2
0 Diﬀusion 49628 [34681, 132980] mL h
 1 0.1882 0.3530
1 Aminotransferases
(Transamination)
LEU 1.816 [0.000, 4.629] day
 1 0.2679  0.0187
2 HIS 16.29 [3.42, 620.16] day
 1 0.0251  0.2948
3 ARG 100.00 [88.75, 2655] day
 1  0.1430 0.2253
4 VAL 1.147 [0.428, 23.112] day
 1 0.2506  0.0617
5 TRP 15.99 [7.42, 833.88] day
 1 0.2022  0.1063
6 PHE 4.148 [1.740, 9.520] day
 1 0.2595  0.0364
7 ILE 3.723 [0.000, 6.213] day
 1 0.2491  0.0268
8 ALA 1.573 [0.000, 6.213] day
 1 0.2514 0.0135
9 TYR 1.135 [0.559, 3.450] day
 1 0.1866  0.2730
10 LYS 0.192 [0.000, 2.164] day
 1 0.2358 0.0053
11 Other speciﬁc reactions MET 34.53 [7.27, 284.76] day
 1 0.2587 0.1171
12 SER 10.80 [3.34, 102.71] day
 1 0.2698 0.0399
13 GLY 10.76 [2.69, 251.25] day
 1 0.2674 0.0849
14 THR 9.326 [3.16, 420.70] day
 1 0.2543  0.0546
15 Asparaginase 0.0009 [0.0000, 0.002] day
 1 lmol
 1 L 0.1825 0.4175
16 3.593 [1.215, 8.505] day
 1 0.2254 0.2971
17 AST 50.08 [39.25, 59.37] day
 1  0.0650 0.0341
18 GOT 56.73 [50.35, 71.85] day
 1 0.1819 0.1456
19 Urea Cycle Km (ASP) 225.76 [187.7, 378.9] day
 1 lmol
 1 L 0.2000  0.3185
20 5.00 [0.9375, 6.17] lmol L
 1  0.1023 0.1813
21 GS 0.0033 [0.001, 0.007] day
 1 lmol
 1 L 0.1198  0.1839
22 0.0205 [0.001, 0.039] day
 1 0.1017  0.3917
23 GLDH, Protein Synthesis 40.68 [24.12, 50.38] day
 1 0.1121 0.0330
24 0.5475 [0.465, 0.813] –  0.0057  0.1114
336estimated over the 18 runs have values between 0.54
and 0.987 with the median of 0.87 and the mean of
0.84. The values of these 11 parameters are high for
six of the seven high performance runs and low for
run H7 as well as for the medium and low perfor-
mance runs as shown in Table 4 for parameter p1. The
value of the parameter p1 is strongly correlated with
the bioreactor performance (p-value 0.00017 by the
two-sided t-test of pm values of high versus medium or
low performance runs). The mean value of the
parameter p1 averaged over the high performance runs
equals 2.84 (±1.77). The parameter is zero for all low
performance runs. In Fig. 8 the medium and low
performance runs are displayed in the left part
Table 3 Values of the parameters pm of the model (2) with the values of the scaled mean square error (mse) as identiﬁed by individual
model ﬁts to the seven high performance runs H1–H7
m H1 H2 H3 H4 H5 H6 H7
0 93762 48599 154190 60636 318770 94939 81010
1 2.4364 2.1102 2.7550 3.7578 5.8576 2.9302 0
2 224.4944 5.1335 36.9058 50.8039 38.0362 2.9139 21.9417
3 342.2608 285.5303 79.9927 97.7853 55.3615 89.3504 2789
4 1.5042 1.9442 1.3383 2.2465 3.2348 2.2254 0
5 8.3918 12.4793 19.5866 88.6396 44.3098 19.8193 4.8666
6 2.8625 3.7943 8.6391 10.5712 11.0843 4.0756 0.8345
7 4.8314 6.4938 4.0010 6.0186 10.1770 6.6223 0.0102
8 3.5440 0.9192 1.7771 2.0325 5.8235 2.7174 0
9 2.1389 1.5629 2.4463 1.5746 1.2908 0.8548 0
10 0 0.0 2.2151 1.5213 1.6998 0.4708 0
11 10.8005 24.3783 83.0280 53.8904 116.5868 25.3813 12.9908
12 10.0767 9.4709 21.1218 16.3735 31.1820 10.2536 3.3815
13 10.0573 5.1397 27.4213 22.6315 45.1116 10.2223 3.2532
14 11.6650 7.2170 8.5069 22.0442 25.2093 12.4954 3.0131
15 0.0008 0.0007 0.0018 0.0007 0.0129 0.0008 0.0007
16 5.1580 3.4742 3.8554 7.1251 30.9168 3.7947 1.2083
17 40.4685 59.4058 37.9076 63.5569 60.3473 43.3760 69.3468
18 69.9174 57.3297 72.5782 70.4225 109.7867 52.5201 63.2809
19 291.5727 192.9329 341.5933 334.0218 238.6410 263.7827 111.2798
20 5.5669 8.4229 3.2504 4.8261 3.8251 3.7808 8.6594
21 0.0014 0.0 0.0114 0.0026 0.0006 0.0052 0.0034
22 0.0513 0.0 0.0031 0.0280 0.0004 0.0157 0.0000
23 52.5970 35.6001 51.8982 49.6467 67.2338 39.3603 26.0489
24 0.5707 0.6833 0.1963 0.5933 0.6132 0.6823 0.6408
mse 0.0162 0.0143 0.0202 0.0115 0.0135 0.0145 0.0321
Fig. 5 Measured data of the 20
variables of bioreactor run H1
with the simulated kinetics of
the model ﬁtted to the data of
H1
337describing low transamination and oxidative deami-
nation activities whereas six of the seven high
performance runs (with the exception of run H7) are
displayed in the right part representing high trans-
amination and oxidative deamination activities.
Some parameters are highly correlated over the 18
runs with a correlation coeﬃcient r of more than 0.98,
e.g., the parameters p11 and p13 (representing the
catabolism of methionine and glycine) as well as p4 and
p7. Also, the parameter p1 is highly correlated (r>0.96)
with the parameters p4 and p7. The high correlation of
the parameters p1, p4,a n dp7 representing the transam-
ination of LEU, ILE and VAL can be hypothetically
explained by the fact that LEU, ILE and VAL are
branched-chain amino acids which cannot be transami-
nated in hepatocytes. To transaminate these amino
acids, the activity of non-parenchymal liver cells is
required.
Among the high performance runs there are further
individual diﬀerences that are displayed in Fig. 8 by a
Fig. 7 Measured and simulated
kinetics as in Fig. 5, but for run
H7
Fig. 6 Measured and simulated
kinetics as in Fig. 5, but for run
H5
338low second principal component PC_2 (e.g., high values
of the parameters p2 and p22 for run H1) and a high
PC_2 (e.g., low values of the parameters p2 and p22 for
runs H2, H5, and H7). The parameters p2 and p22
represent the uptake of histidine and glutamine (see
Table 2). As shown in Fig. 5 for run H1, the high
parameter value p2 results in a low stationary concen-
tration of HIS and the high parameter value p22 results
in high NH3 and low GLU levels. These eﬀects could be
related to the amino acid transport system N (SN1) that
mediates speciﬁcally the uptake of histidine and gluta-
mine [14]. The parameter p21 that represents the activity
of GS was found to be very low for the high perfor-
mance runs H2 and H5 (see Table 3). GS plays an
important role in the spatial organization (zonation) of
the liver and is exclusively expressed in pericentrally
located hepatocytes [15]. The low GS activity in the high
performance runs H2 and H5 could therefore be caused
by a high proportion of periportal versus pericentral
hepatocytes in the cell preparations for these two runs.
Conclusion
The kinetics of 18 amino acids and the related nitrogen-
containing compounds NH3 and UREA in a primary
human liver cell bioreactor were analyzed and modeled
using a diﬀerential equation system. The model focuses
on the kinetics of GLU and ASP as well as on the for-
mation and elimination of NH3 and the synthesis of
UREA. It describes the degradation of amino acids by
transamination, oxidative deamination and other
speciﬁc reactions. In addition, the activities of selected
enzymes such as AST, GOT, GS, and GLDH as well as,
in a more aggregated form, the activities of urea cycle
enzymes are included. The diﬀerential equation system
Table 4 Parameters for the 18 liver cell bioreactor runs: tB as used
in Eq. (1); the star (*) for run 13 denotes that the feed FB(t) was
switched on during the period from the second to the fourth day;
the scaled mean square error (mse) and the parameters p1, p2, and
p22 as used in Eq. (2) were identiﬁed by model ﬁtting to the data of
the high performance runs H1–H7 (averaged) and of the individual
high performance runs H1,..., H7, medium performance runs
M8,..., M14 and low performance runs L15,..., L18
Run No. tB [d] mse
[-]
p1
[d
 1]
p2
[d
 1]
p22*1,000
[d
 1]
H1-H7
(averaged)
3 0.0099 1.816 16.29 20.5
H1 3 0.0162 2.4364 224.4944 51.2761
H2 3 0.0143 2.1102 5.1335 0
H3 3 0.0202 2.7550 36.9058 3.1020
H4 3 0.0115 3.7578 50.8039 28.0101
H5 3 0.0135 5.8576 38.0362 0.4057
H6 3 0.0145 2.9302 2.9139 15.7285
H7 3 0.0321 0 21.9417 0.0186
M8 3 0.0147 1.0367 8.7742 0.0497
M9 5 0.0330 0 2.8611 0.0381
M10 5 0.0199 0.0008 11.2947 0.0578
M11 3 0.0313 0.0010 32.3658 0.2347
M12 3 0.0259 0.9387 168.2299 0.0722
M13 2–4* 0.1559 0.0003 11.6439 0.1391
M14 3 0.0492 0.0003 10.9787 0.1615
L15 0 0.2747 0 39.9225 0.0572
L16 6 0.0803 0 2.5935 0.0268
L17 3 0.0864 0 137.2721 0.0131
L18 3 0.1321 0 1.2613 0.0560
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Fig. 8 Biplot of the ﬁrst and
second principal components of
the model parameter matrix
{p0,...,p24} as identiﬁed for the
18 liver cell bioreactor runs
(high performance runs
H1,...,H7, medium performance
runs M8,...,M14, low
performance runs L15,...,L18)
339does not represent a fully mechanistic but rather a
phenomenological model since essential metabolic
activities had to be neglected because they cannot be
identiﬁed based on the measured data.
The diﬀerential equation system allows the analysis of
a number of representative liver cell functions in terms of
their kinetic behavior. The identiﬁcation of the model
parameters by ﬁtting the model responses to the
measured data was used to generate hypotheses about
the causes of speciﬁc diﬀerences between the bioreactor
runs. The model ﬁts were found to be very satisfactory
for eight high and medium performance runs. The model
is however inadequate for low performance runs and
with respect to the LYS kinetics also for high perfor-
mance runs. This is probably caused by the neglection
of proteases activities in the model that appear to be
relevant for low and medium performance runs. Both,
protein synthesis and degradation could not be modeled
in detail due to the lack of representative protein
measurements.
The applied model based analysis of data obtained
from the bioreactor system can be used to quantitatively
evaluate the functional state of liver cell cultures under
high performance conditions intended for clinical
application in extracorporeal liver support systems. The
approach can also be used to study the eﬀect of several
exogenous factors, e.g., of hormones or drugs, on
hepatocyte metabolism in vitro. The model based
analysis methods applied here therefore provide suitable
tools for in silico studies supplementing in vitro studies
of hepatocyte functions in a systems biological way.
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